Cooper Companies (NYSE:COO) had its price objective raised by BMO Capital Markets from $294.00 to $306.00 in a research report released on Friday, The Fly reports. The brokerage currently has an outperform rating on the medical device company’s stock.
A number of other brokerages have also commented on COO. Oppenheimer set a $270.00 price objective on Cooper Companies and gave the company a hold rating in a report on Friday, August 31st. Raymond James increased their price objective on Cooper Companies from $270.00 to $300.00 and gave the company an outperform rating in a report on Friday, September 21st. KeyCorp lowered their price objective on Cooper Companies from $298.00 to $296.00 and set an overweight rating on the stock in a report on Friday. Zacks Investment Research lowered Cooper Companies from a buy rating to a hold rating in a report on Thursday, August 16th. Finally, ValuEngine raised Cooper Companies from a hold rating to a buy rating in a report on Thursday, September 27th. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The company has a consensus rating of Buy and a consensus price target of $284.50.
Shares of NYSE COO traded down $34.02 during mid-day trading on Friday, reaching $243.01. 1,253,678 shares of the company traded hands, compared to its average volume of 333,174. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.54 and a current ratio of 2.58. The firm has a market cap of $13.61 billion, a price-to-earnings ratio of 21.13, a P/E/G ratio of 2.13 and a beta of 0.77. Cooper Companies has a fifty-two week low of $216.47 and a fifty-two week high of $283.18.
In related news, Director A Thomas Bender sold 7,150 shares of the stock in a transaction that occurred on Monday, September 24th. The stock was sold at an average price of $269.36, for a total transaction of $1,925,924.00. Following the completion of the sale, the director now owns 18,355 shares in the company, valued at approximately $4,944,102.80. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Daniel G. Mcbride sold 10,310 shares of the stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $264.44, for a total value of $2,726,376.40. Following the sale, the chief operating officer now owns 38,705 shares of the company’s stock, valued at approximately $10,235,150.20. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 20,691 shares of company stock valued at $5,527,869. 1.60% of the stock is owned by corporate insiders.
Large investors have recently made changes to their positions in the stock. Resources Management Corp CT ADV bought a new stake in Cooper Companies during the 3rd quarter valued at approximately $203,000. Engineers Gate Manager LP bought a new stake in Cooper Companies during the 3rd quarter valued at approximately $208,000. Zeke Capital Advisors LLC bought a new stake in Cooper Companies during the 3rd quarter valued at approximately $209,000. Boston Private Wealth LLC bought a new stake in Cooper Companies during the 3rd quarter valued at approximately $213,000. Finally, Raymond James Trust N.A. bought a new stake in Cooper Companies during the 3rd quarter valued at approximately $214,000.
Cooper Companies Company Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Recommended Story: What Is An Exchange-Traded Fund (ETF)?
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.